Best practice in primary care pathology: Review 8

Journal of Clinical Pathology

Volumn 60, Issue 7, 2007, Pages 740-748

  Smellie, W S A ^a   Hampton, K K ^b   Bowlees, R ^c   Martin, S C ^d   Shaw, N ^c   Hoffman, J ^a   Ng, J P ^e   Mackenzie, S M ^f   Van Heyningen, C ^g  

^a BISHOP AUCKLAND GENERAL HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c Sowerby Centre for Health Informatics   (United Kingdom)

^d WEST SUFFOLK HOSPITAL   (United Kingdom)

^e BARNSLEY HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM ION;

CLINICAL EDUCATION; CONSENSUS DEVELOPMENT; CONTINUING EDUCATION; EMBASE; EVIDENCE BASED PRACTICE; GOOD CLINICAL PRACTICE; HEALTH CARE POLICY; HUMAN; HYPERNATREMIA; HYPONATREMIA; LABORATORY DIAGNOSIS; LUNG CANCER; MEDLINE; OCCULT BLOOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SPUTUM CYTODIAGNOSIS;

ANTICOAGULANTS; DRUG MONITORING; EVIDENCE-BASED MEDICINE; HUMANS; HYPERNATREMIA; HYPONATREMIA; LUNG NEOPLASMS; OCCULT BLOOD; PATHOLOGY, CLINICAL; PRIMARY HEALTH CARE; SODIUM; SPUTUM;

EID: 34447308221     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.044719     Document Type: Review

References (70)

1. eMedicine. Hypernatraemia. www.emedicine.com/emerg/topic263.htm (accessed 10 Aug 2006).
2. EBM. Hypernatraemia. www.ebm-guidelines.com.
3. Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med, 342:1493-9.
4. Kugler JP, Hustead T. Hyponatraemia and hypernatraemia in the elderly. Am Fam Physician 2000;61:3623-30.
5. Reynolds RM, Padfield PL, Seckl JR. Disorders of sodium balance. BMJ 2006;332:702-5.
6. EBM. Hyponatraemia. www.ebm-guidelines.com.
7. Milionis HJ, Liamis GL, Elisat MS. The hyponatraemic patient: a systematic approach to laboratory diagnosis. CMAJ 2002;166:1056- 62.
8. eMedicine. Hyponatraemia. October 2005 update. www.emedicine.com/emerg/topic275.htm (accessed 10 Aug 2006).
9. Oh MS. Pathogenesis and diagnosis of hyponatraemia. Nephron. 2002;92: 2-8, Prodigy.www.prodigy.nhs.uk, (Suppl 1).
10. Prodigy. Guidance on suspected lower gastro-intestinal cancer. http://www.prodigy.nhs.uk/gi_lower_cancer_suspected/view_whole_guidance (accessed 30 Oct 2006).
11. NICE. Clinical guideline 27. Referral for suspected cancer, 2005.http://www.nice.org.uk/page.aspx7o=cg027niceguideline (accessed 2 Oct 2006).
12. SIGN. Management of colorectal cancer. SIGN, 2003. http://www.sign.ac.uk/pdf/sign67.pdf (accessed 2 Oct 2006).
13. Thomas WM, Pye G, Hardcastle JD, et al. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests. Br J Surg 1990;77:277-9.
14. Greegor DH. Occult blood testing for detection of asymptomatic colon cancer. Cancer 1971;28:131-4.
15. Tate JJ, Northway J, Royle GT, et al. Faecal occult blood testing in symptomatic patients: comparison of three tests. Br J Surg 1990;77:523-6.
16. Pye G, Jackson J, Thomas WM, et al. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients. Br J Surg 1990;77:630-1.
17. Thomas WM, Hardcastle JD, Jackson J, et al. Chemical and immunological testing for faecal occult blood: a comparison of two tests in symptomatic patients. Br J Cancer 1992;65:618-20.
18. Moran A, Husband D, Jones AF, et al. Diagnostic value of a Guaiac occult blood test and faecal alpha 1 -antitrypsin. Gut 1995;36:87-9.
19. UKCCSPG. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004;329:133.
20. Leicester RJ, Lightfoot A, Millar J, et al. Accuracy and value of the Haemoccult test in symptomatic patients. Br Med J (Clin Res Ed) 1983;286:673-4.
21. von Krogh H, Siem H. Letter. BMJ 1983;287:216.
22. Falkson CB, Bates T. Faecal occult blood screening for patients with gastrointestinal symptoms. Br J Surg 1993;80:1326.
23. Goulston K, Davidson P. Faecal occult blood testing in patients with colonic symptoms. Med J Aust 1980;2:667-8.
24. Niv Y, Sperber AD. Sensitivity, specificity, and predictive value of fecal occult blood testing (Hemoccult II) for colorectal neoplasia in symptomatic patients: a prospective study with total colonoscopy. Am J Gastroenterol 1995;90:1974-7.
25. Thomas WM, Pye G, Hardcastle JD, et al. Role of dietary restriction in Haemoccult screening for colorectal cancer. Br J Surg 1989;76:976-8.
26. Cancer Society. http://www.cancer.org/docroot/CRI/conlent/ CRI_2_6X_Colorectal_Cancer_Early_Detection_10.asp (accessed 30 Oct 2006).
27. State of New Jersey. Department of Health and Senior Sciences. Guideline Comparison. www.state.nj.us/health/ccp/guidelines.htm (accessed 30 Oct 2006).
28. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006;367:404-11.
29. Fitzmaurice DA, Murray ET, Gee KM, et al. A randomised controlled trial of patient self management of oral anticoagulation treatment compared with primary care management. J Clin Pathol 2002;55:845- 9.
30. Fitzmaurice DA, Hobbs FDR, Murray ET, et al. Oral anticoagulation management in primary care with the use of computerised decision support and near-patient testing: a randomised, controlled trial. Arch Intern Med 2000;160:2343-8.
31. Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition-2005 update. Br J Haematol 2005;132:277-85.
32. Ansell J, Hirsh J, Poller L, et al. The pharmacology and measurement of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:204-33.
33. Fennerty A, Dolben J, Thomas P, et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. BMJ 1984;288:1268-70.
34. Guidelines on oral anticoagulation: third edition. Br J Haematol 1998;101:374-87.
35. Tait RC, Sefcick A. A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation. Br J Haematol 1998;101:450-4.
36. British National Formulary 51. March 2006. http://www.bnf.org/bnf/ (accessed 30 Oct 2006).
37. National Institutes of Health (Office of Dietary Supplements). http://dietary-supplements.info.nih.gov/ (accessed 30 Oct 2006).
38. National Center for Complementary and Alternative Medicine. http://nccam.nih.gov (accessed 30 Oct 2006).
39. Lidstone V, Janes S, Stross P. INR: intervals of measurement can safely extend to 14 weeks. Clin Lab Haem 2000;22:291-3.
40. Poller L, Schaich CR, MacCallum PK, et al. On behalf of the European Concerted Action on Anticoagulation. Lancet 1998;352:1505-9.
41. Baglin T. Management of warfarin (coumarin) overdose. Blood Rev 1998;12:91-8.
42. Wittowsky AK. Drug interactions update: drugs, herbs, and oral anticoagulation. J Thromb Thrombolysis 2001;12:67-71.
43. Holbrook AM, Pereira JA, Labris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005;165:1095-106.
44. 1-depleted patients. Thromb Haemost 2004;92:1018-24.
45. US Preventative Services Task Force. Screening for lung cancer. http://odphp.osophs.dhhs.gov/pubs/guidecps/text/CH11.txt (accessed 26 May 2006).
46. Marfin AA, Schenker MB. Screening for lung cancer: effective tests awaiting effective treatment. In: Harber P, Balmes JR, eds. Occupational medicine state of the art review:prevention of pulmonary disease. Philadelphia: Hanley & Belfus, 1991:111-31.
47. The National Cancer Institute Cooperative Early Lung Cancer Detection Program. Summary and conclusions. Am Rev Respir Dis 1984;130:565-7.
48. Erozen YS, Frost JK. Cytopathologic diagnosis of lung cancer. Semin Oncol 1974;1:191-8.
49. Koss LG, Melamed LR, Goodner JT. Pulmonary cytology, a brief survey of diagnostic results from July 1st 1952 until December 31st 1960. Acta Cytol 1964;8:104-13.
50. Bocking A, Biesterfield S, Chatelain R, et al. Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum. Sensitivity and specificity of an alteration to routine cytology. Acta Cytol 1992;36:37-47.
51. Johnston WW, Bossen EH. Ten years of respiratory cytopathology at Duke University Medical Center. I. The cytopathologic diagnosis of lung cancer during the years 1970 to 1974, noting the significance of specimen number and type. Acta Cytol 1981;25:103-7.
52. DeMay RM. Respiratory cytology. In: The art and science of cytopathology. Chicago: ASCP Press, 1996.
53. American Society of Cytopathology. Non-gynecology practice guideline. http://www.cytopathology.org/website/article.asp?id=17 (accessed 26 May 2006).
54. Office of Cancer Control and Prevention. Guideline comparisons. http://www.state.nj.us/health/ccp/guidelines.htm (accessed 26 May 2006).
55. Wright JL, Coppin C, Mullen BJ, et al. Surgical treatment of lung cancer: promise and problems of early diagnosis. Can J Surg 1986;29:205-8.
56. Rivera MP, Detterbeck F, Mehta AC. Diagnosis of lung cancer: the guidelines. Chest 2003;123(1 Suppl):129S-36S.
57. Prodigy. Guidance. Lung cancer-suspected. http://www.prodigy.nhs. uk/guidance.asp?gt=Lung%20cancer%20-%20suspected (accessed 26 May 2006).
58. Department of Health. Referral guidelines for suspected cancer. http://www.dh.gov.uk/assetRoot/04/01/44/21/04014421.pdf (accessed 26 May 2006).
59. White Paper. The new NHS-modern dependable. http://www.archive. official-documents.co.uk/document/doh/newnhs/newnhs.htm (accessed 26 May 2006).
60. Smellie WSA, Wilson D, McNulty CAM, et al. Best practice in primary care pathology: review 1. J Clin Pathol 2005;58:1016-27.
61. Smellie WSA, Forth J, McNulty CAM, et al. Best practice in primary care pathology: review 2. J Clin Pathol 2006;59:113-20.
62. Smellie WSA, Forth J, Bareford, et al. Best practice in primary care pathology: review 3. J Clin Pathol 2006;59:781-9.
63. Smellie WSA, Forth J, Sundar S, et al. Best practice in primary care pathology: review 4. J Clin Pathol 2006;59:893-902.
64. Smellie WSA, Forth J, Ryder S, et al. Best practice in primary core pathology: review 5. J Clin Pathol 2006;59:1229-37.
65. Smellie WSA, Forth J, Coleman JJ, et al. Best practice in primary care pathology: review 6. J Clin Pathol 2007;60:225-34.
66. Smellie WSA, Forth J, Smart SRS, et al. Best practice in primary care pathology: review 7. J Clin Pathol 2007;60:458-65.
67. Smellie WSA, Wilson D, Finnigan DI, et al. Best practice in pathology. methodology for constructing guidance. J Clin Pathol 2005;58:249-53.
68. General Medical Services Contract. www.nhsconfed.org/docs/ contract.pdf (accessed 3 Oct 2005).
69. NHS Confederation. Quality and outcomes framework. Accompanying guidance document. 2003. NHS Confederation. www.nhsconfed.org/docs/ quality_and_outcomes_framework_guidance.pdf (accessed 3 Oct 2005).
70. NHS. Revisions to the GMS contract 2006/7. http://www. nhsemployers.org/primary/index.cfm (accessed 3 March 2006).